Logo Logo

Publications by Krämer, D.

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date
Number of items: 2.

Journal article

Metzgeroth, G.; Schwaab, J.; Naumann, N.; Haferlach, C.; Jawhar, M.; Horny, H.-P.; Dirk, J.; Kratz-Albers, K.; Krämer, D.; Mayer, S.; Storch, N.; Burchert, A.; Haferlach, T.; Cross, N. C. P.; Hofmann, W.-K.; Fabarius, A.; Reiter, A. (2017): Clinical characteristics and treatment with ruxolitinib in patients with PCM1-JAK2 and BCR-JAK2 positive myeloid/lymphoid neoplasms with eosinophilia. In: Oncology Research and Treatment, Vol. 40: p. 196

Theis, F.; Corbacioglu, A.; Gaidzik, V. I.; Paschka, P.; Weber, D.; Bullinger, L.; Schlegelberger, B.; Göhring, G.; Köhne, C.-H.; Krämer, D.; Germing, U.; Brossart, P.; Horst, H.-A.; Haase, D.; Götze, K.; Ringhoffer, M.; Fiedler, W.; Nachbaur, D.; Kindler, T.; Held, G.; Lübert, M.; Wattad, M.; Salih, H. R.; Krauter, J.; Heuser, M.; Thol, F.; Ganser, A.; Döhner, H.; Schlenk, R. F.; Döhner, K. (2017): Clinical Impact of TET2 Mutations in Acute Myeloid Leukemia Patients Harboring CEBPA Mutations: A Study of the AML Study Group (AMLSG). In: Hämatologica, Vol. 102: pp. 203-204

This list was generated on Tue Aug 11 01:58:36 2020 CEST.